Octopus Biosafety Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	0.05	0.23	0.02	0.07	0.22
Revenue Growth	-77.19%	952.01%	-67.37%	-70.08%	-
Cost of Revenue	-0.26	0.34	0.28	0.57	0.54
Gross Profit	0.31	-0.11	-0.26	-0.5	-0.32
Selling, General & Admin	0.76	0.88	0.75	1.09	1.1
Depreciation & Amortization Expenses	0.38	0.25	0.24	0.49	0.48
Other Operating Expenses	-0.6	0.28	-0.37	-0.48	-0.42
Total Operating Expenses	0.54	1.41	0.63	1.1	1.16
Operating Income	-0.84	-1.44	-0.73	-1.12	-1.4
Interest Income	-	-	-	0	0
Interest Expense	-0	-0	-0	-0.01	-0.01
Other Non-Operating Income (Expense)	-0.03	-0.53	-0.23	-0.13	0.35
Total Non-Operating Income (Expense)	-0.03	-0.53	-0.23	-0.14	0.34
Pretax Income	-0.84	-1.44	-0.73	-1.13	-1.41
Provision for Income Taxes	0.21	0.19	0.16	0.25	0.23
Net Income	-1.05	-1.63	-0.89	-1.38	-1.64
Net Income to Common	-0.66	-1.78	-0.8	-1.01	-0.83
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	15	15	4	4	4
Shares Outstanding (Diluted)	15	15	4	4	4
Shares Change	-	264.60%	-0.07%	-	100.15%
EPS (Basic)	-0.04	-0.12	-0.20	-0.25	-0.21
EPS (Diluted)	-0.04	-0.12	-0.20	-0.25	-0.21
EPS Growth	-	-	-	-	-
Gross Margin	594.04%	-49.82%	-1190.17%	-753.97%	-143.72%
Operating Margin	-1601.09%	-627.05%	-3329.84%	-1676.21%	-627.37%
Profit Margin	-2003.12%	-711.89%	-4070.26%	-2058.12%	-734.48%
EBITDA	-0.84	-1.44	-0.73	-1.12	-1.4
EBIT	-0.84	-1.44	-0.73	-1.12	-1.4
EBIT Margin	-1601.09%	-627.05%	-3329.84%	-1676.21%	-627.37%
Effective Tax Rate	-24.93%	-13.26%	-21.46%	-21.83%	-16.33%